COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
PR Newswire•30/09/2026•17:21 ET
0
Key Highlights
- ➤LightSolver acquisition completed, expanding CollPlant (CLGN) into photonic computing
- ➤HPC benchmarks showed approximately 40× to more than 80,000× acceleration versus GPU algorithms
- ➤Q2 GAAP revenue $108,000 versus $179,000 in 2025
- ➤Q2 GAAP net loss $2.7 million, or $1.89 basic loss per share
- ➤Cash and equivalents $2.6 million as of June 30, 2026
Expert Statements
Yehiel Tal, Chief Executive Officer of CollPlant Biotechnologies
“The acquisition of LightSolver marks CollPlant's strategic entry into high-performance computing (HPC) and photonics computing markets, alongside our regenerative medicine activities. LightSolver's pioneering LPU technology, recently validated in a peer-reviewed study with Germany's HLRS demonstrating acceleration of fundamental HPC workloads by up to 80,000 times, provides an exciting opportunity to diversify our portfolio and create long-term shareholder value. We are also pleased to welcome LightSolver co-founder Dr. Ruti Ben Shlomi to our Board, bringing deep scientific and entrepreneurial expertise as we advance the technology toward commercialization.”
Yehiel Tal, Chief Executive Officer of CollPlant Biotechnologies
“Concurrently, we remain committed to our leadership in regenerative medicine. We are actively advancing our proprietary plant-derived rhCollagen platform and continue to dedicate significant resources toward establishing strategic partnerships with leading global players to utilize our technology in medical aesthetics and 3D bioprinting of tissues and organs.”
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire
Strategic Expansion into Photonic Computing via LightSolver Acquisition Diversifies Technology Portfolio Alongside Continued Innovations in Regenerative Medicine
Get started
Create a free account to read the full story.